Author: News Room
HYDERABAD, India, April 03, 2025 (GLOBE NEWSWIRE) — Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), has inaugurated a dedicated Peptide Research Center at its integrated R&D Campus in Hyderabad, India. Announcing the launch, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said: “As the pharmaceutical industry evolves from small molecules to emerging modalities like peptides, we are expanding our capabilities to stay ahead. Our new Peptide Research Center reflects this commitment—designed to meet the growing demand for complex peptide synthesis and conjugation. With this investment, we reinforce our…
BURLINGTON, Ontario, April 03, 2025 (GLOBE NEWSWIRE) — Bunzl Canada is thrilled to announce the launch of its Carbon Footprint Calculator, an innovative tool designed to help businesses measure and reduce the carbon intensity of their delivery program. The Carbon Footprint Calculator quantifies emissions from deliveries Bunzl makes to its customers on a regular basis. This offers businesses a clear understanding and measurement of the associated carbon footprint. More importantly, it enables customers to explore optimized delivery schedules that could lead to significant carbon footprint reductions and contribute to corporate sustainability goals. “At Bunzl Canada, we recognize that our customers…
AURORA, Colo., April 03, 2025 (GLOBE NEWSWIRE) — Arialief caught my attention from the very first day I heard about it. It’s not every day I commit to testing a new supplement for over three months and then share my personal journey. As someone who has struggled with stubborn neuropathy—burning, tingling, and numbness in my feet, plus aches shooting up my legs—I’m well aware of how often big promises lead to underwhelming results. Yet Arialief stood out because of its unique focus on rapid discomfort relief, comprehensive metabolic support, and long-term nerve health. The brand claims that by combining natural,…
TORONTO, April 03, 2025 (GLOBE NEWSWIRE) — Homeownership in the Greater Toronto Area (GTA) became more affordable in March 2025 compared to the previous year. On average, both borrowing costs and home prices have declined over the past year, making monthly payments more manageable for households looking to buy a home. “Homeownership has become more affordable over the past 12 months, and we expect further rate cuts this spring. Buyers will also benefit from increased choice, giving them greater negotiating power. Once consumers feel confident in the economy and their job security, home buying activity should improve,” said Toronto Regional…
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — Now available exclusively to GlobeNewswire® clients, a new partnership between Notified and SWNS helps communicators boost the impact of their press releases by sharing their stories in trusted, high-profile UK media outlets. GlobeNewswire clients who select the “Amplify UK” circuit within the platform will have releases distributed across a network of 65 regional media websites, prominently labeled as “Must Read – Ad Feature by SWNS” to drive visibility and reader engagement. SWNS is an independent, UK-based provider of breaking news, trending stories, pictures and videos, delivering high-quality content to a wide range…
ST. PETERSBURG, Fla., April 03, 2025 (GLOBE NEWSWIRE) — Prime Biome caught my attention the very first day I heard about it. It’s not every day that I commit to a new supplement for nearly four months and then share my entire journey. But after experiencing countless supposed “gut-health miracles” and “skin-clearing probiotics” that yielded mediocre results, I was eager to give Prime Biome a real test. Unlike typical probiotics that only focus on one aspect (usually digestion or immunity), Prime Biome promises a dual-action approach: it targets both gut and skin health simultaneously by utilizing advanced probiotic strains combined…
HONG KONG, April 03, 2025 (GLOBE NEWSWIRE) — CoinEx, a leading cryptocurrency exchange, has reaffirmed its commitment to transparency, security, and user trust with an updated asset reserve ratio as of March 31, 2025, at 08:00 (UTC). Maintaining a 1:1 reserve ratio, CoinEx ensures that for every $1 in user deposits, it holds an equivalent amount in reserves, safeguarding users’ funds and reinforcing its financial stability. CoinEx maintains a reserve rate of CET at 122.3%. The reserve rate for major assets, including USDT, USDC, BTC, ETH and DOGE are 118.5%, 102.34%, 100.98%, 100.08% and 100% respectively. The total Market Cap…
London, April 03, 2025 (GLOBE NEWSWIRE) — big xyt, a leading independent provider of high-quality European trade data and analytics, today announced its formal intent to become the official provider of the EU Consolidated Tape (CT) for equities and ETFs. The company’s official entry into the bidding process follows overwhelming support from across the financial industry and addresses growing concerns about limited competition in the selection process. With over a decade of experience consolidating European market data, big xyt brings proven expertise in harmonising the complex trading landscape across multiple jurisdictions, venues and currencies. “After careful consideration and in response…
Dublin, April 03, 2025 (GLOBE NEWSWIRE) — The “Advanced Recurrent Ovarian Cancer Market” report has been added to ResearchAndMarkets.com’s offering.The advanced recurrent ovarian cancer market was valued at USD 2.5 billion in 2023, driven by the increasing prevalence and the increasing adoption of targeted drug therapies. The market is expected to grow at a CAGR of 8.4%, likely to reach a value of USD 5.5 billion by 2032. Advanced recurrent ovarian cancer is a challenging condition characterised by the recurrence of ovarian cancer after initial treatment. It often requires complex and multimodal therapies, including chemotherapy, immunotherapy, and targeted drug treatments.…
Dublin, April 03, 2025 (GLOBE NEWSWIRE) — The “Esophageal Cancer Market” report has been added to ResearchAndMarkets.com’s offering.The esophageal cancer market was valued at USD 1.3 billion in 2023, driven by robust research efforts aimed at discovering new treatment options and improving existing therapies across the 8 major markets. The market is expected to grow at a CAGR of 9% during the forecast period 2024-2032, reaching a market value of USD 2.8 billion by 2032. Progress in treatment technologies, including immunotherapies, targeted drug therapies, and minimally invasive surgeries, is transforming patient outcomes. These innovations provide more effective and personalised treatment…